Beta-Blockers, Arbs, And Other Medical Therapies In Loeys-Dietz Syndrome
Published on: October 5, 2025
Beta-Blockers, ARBs, and Other Medical Therapies in Loeys-Dietz Syndrome
Article author photo

Ishwaq Abdullahi

MSc in Drug Discovery and Pharma Management, University College London (UCL)

Article reviewer photo

Dafne Espinal Pena

PharmD, University of Maryland

Overview

Loeys-Dietz Syndrome (LDS) is a rare genetic connective tissue disorder that results in cardiovascular, skeletal, and craniofacial issues. Genetic mutations that affect the transforming growth factor-beta (TGF-β) pathway are the cause of this condition. Cell division and development are fundamentally regulated by this pathway, and the mutations result in disruptions to various systems across the body. Cardiovascular issues are the most reported conditions in LDS patients with research highlighting two thirds of patients experiencing aortic root aneurysms. Beta-blockers are often used to reduce blood pressure and heart rate to diminish stress on the aorta and other blood vessels. Angiotensin receptor blockers (ARBs) can also be prescribed to block the hyperactive TGF-β pathway. These drugs are essential for postponing or avoiding aortic aneurysms and dissections in individuals with LDS. Surgical interventions are another medical therapy employed by healthcare professionals to treat deformities caused by damage to the various parts of the body.

What is Loeys-Dietz syndrome?

Loeys-Dietz Syndrome (LDS) is a rare genetic condition that affects the body’s connective tissues. This condition is caused by genetic alterations (mutations) which are involved in the transforming growth factor-beta (TGF-β) pathway. This pathway plays a fundamental role in controlling cell development and division1. LDS can be passed down from parent to child. This means if one parent has the gene change, each of their children has a 50% chance to get the same condition (autosomal dominant). Even with this, many LDS cases show up in people who do not have a family history of the syndrome.2

LDS subtypes and associated genes:2,6

  • TGFBR1- Loeys-Dietz syndrome 1
  • TGFBR2-Loeys-Dietz syndrome 2
  • SMAD3- Loeys-Dietz syndrome 3
  • TGFB2-Loeys-Dietz syndrome 4
  • TGFB3-Loeys-Dietz syndrome 5
  • SMAD2- Loeys-Dietz syndrome 6

Characteristics of Loeys-Dietz syndrome

LDS is mainly associated with the connective tissue, and it can affect multiple systems within the body. LDS manifests vary between individuals, resulting in unique experiences despite having the same condition.

 LDS usually affects the following bodily regions and systems:

Cardiovascular system

One of the most well reported features of LDS is the effects on the cardiovascular system:

  • Aortic aneurysms: the enlargement of the aorta ( blood vessel responsible for circulating oxygen from the heart to rest of the body) is the most common sign with two thirds of LDS patients having an aortic root aneurysm (enlargement at the base of the aorta) at diagnosis3 
  • Arterial tortuosity: where one or more arteries develop many unusual twists or curves, which likely developed because the blood vessels grew longer than normal.4 This twisting is especially common in the head and neck arteries, and is one of the key features doctors look for when diagnosing LDS5
  • Aortic dissection: Aortic dissection is described as the tearing of the aortic wall, which severely disrupts blood flow to vital organs. Without treatment, acute aortic dissection is fatal in about half of cases within the first 48 hours after symptoms begin. It can quickly lead to life-threatening complications such as aortic rupture or a buildup of fluid around the heart (cardiac tamponade)6,7

Skeletal system

Alongside cardiovascular findings, LDS can also be characterised by skeletal manifestations. These include:2

Craniofacial region

Craniofacial deformities can also be signs of LDS. This may present as a wider than normal space between the eyes caused by the eye sockets being set farther apart (hypertelorism); misalignment of the eyes where they do not look in the same direction (strabismus); a uvula presenting as split into two parts especially at the tip (bifid uvula); an opening or gap in the roof of the mouth due to incomplete tissue fusion during early development (cleft palate); and early fusion of one or more skull bones which alters the shape of the head, potentially impacting brain development (craniosynostosis). 

Beta-blockers: Reducing aortic stress

Individuals with LDS face significant cardiovascular challenges due to their abnormal connective tissue structure, which results in weakened arterial walls throughout the body as aforementioned. One of the most important treatment approaches for treating these cardiovascular symptoms in LDS are beta-blockers such as Atenolol and Metoprolol. This class of drugs blocks the effects of stress hormones like adrenaline (epinephrine) on the cardiovascular system and is mostly used to treat heart-related diseases.8

In the case of LDS, beta-blockers provide protection by reducing heart rate and blood pressure at the same time. The aorta and other arteries throughout the body experience less mechanical stress as a result of this dual action. The integrity of already weakened blood arteries and the aorta is maintained by beta-blockers, which reduce the force and frequency with which blood strikes the artery walls .9 This is crucial as it lowers the risk of acute cardiovascular events like aortic dissection, and slows the advancement of arterial enlargement. 

Angiotensin II Receptor Blockers (ARBs): Targeting the Transforming Growth Factor-Beta (TGF-Ꞵ) pathway

Another important class of medications involved in the management of LDS are Angiotensin II Receptor Blockers (ARBs). ARBs like Candesartan and Losartan target the renin-angiotensin system involved in controlling blood pressure and fluid levels. Specifically, they have a special advantage in LDS as they can help modify the TGF-β (transforming growth factor-beta) signalling pathway, which is impaired in LDS.10 

Research shows ARBs provides cardiovascular protection by:10

  • Lowering blood pressure through blocking angiotensin II receptors
  • Reducing arterial wall stress and tension
  • Reducing aortic root growth and aneurysms

Surgical Interventions in Loeys-Dietz syndrome

Surgery is frequently required to treat the more severe and potentially fatal symptoms of LDS, even if medicinal treatments can reduce the disease's progression. Interventions must be highly customised and usually involve a multidisciplinary team because LDS affects numerous systems, most notably the cardiovascular, craniofacial, and skeletal systems.

Cardiovascular surgery

The aorta and arteries require the most important surgical procedures in LDS because of the significant risk of aneurysm rupture, even at smaller vessel sizes than in other connective tissue illnesses.

The following cardiovascular surgical interventions are the most common associated with LDS patients:

  • Aortic Root Replacement: The most frequent and urgent surgical procedure for patients with LDS. It is frequently advised when the aortic diameter reaches 4.0 cm, due to the aggressive nature of vascular disease in LDS2
  • Valve-Sparing Aortic Root Replacement (David Procedure): The replacement of the dilated section of the aorta while maintaining the rest of a patient's own aortic valve. For younger patients, this is frequently recommended11
  • Repair of Other Aneurysms: LDS can cause aneurysms throughout the arterial tree (e.g., head, neck, abdomen, and limbs), which may also require surgical repair

Craniofacial surgery

Craniofacial abnormalities, which are common in LDS, can influence appearance, function, and development, all of which can have an impact on quality of life.

These craniofacial surgical interventions are commonly associated with LDS patients:

  • Cleft Palate and Bifid Uvula Repair: Frequent ear infections, speech issues, and feeding challenges can result from the formation of a Cleft Palate (split in roof of mouth) and Bifid Uvula (split in mouth resulting in two uvulas). Surgical corrections are often performed in early childhood12
  • Repair of Craniosynostosis: In certain LDS patients, the skull's bones may fuse too soon, resulting in an atypical head shape or elevated intracranial (inside the cranium) pressure. Normal brain and skull development can be ensured with early surgical repair2

Orthopaedic surgery

The many skeletal manifestations of LDS can have a substantial effect on an individual’s quality of life, especially if they result in functional limits, decreased mobility, or chronic discomfort. In order to restore or maintain function and structural stability, skeletal defects may need to be corrected surgically due to the connective tissue weakening that is a feature of LDS. Orthopaedic medical professionals usually at first try conservative management with braces or supports but surgical intervention has been successful in patients too.

The skeletal surgical interventions are the performed on LDS patients:

  • Chest wall surgery: To correct the pectus carinatum and excavatum in the chest wall surgical options differ depending on medical advice. Both deformities can be corrected surgically with the Modified Ravitch Procedure, which involves opening the chest, removing malformed cartilage, and realigning the sternum. Additionally, the Pectus excavatum can also be treated with another operation called the Nuss treatment, which involves positioning a curved metal rod behind the sternum and rotating it to push the sternum outward into the correct position13
  • Clubfoot surgery: Surgical correction is usually considered when the deformity has not responded to non-surgical methods. This may involve extending the tendons in the foot or transferring tendons from other sites to the foot or joint and foot alignment procedures
  • Spinal surgery: Spinal deformity, including scoliosis and kyphosis, are two of the most prevalent and difficult skeletal conditions associated with LDS. These abnormalities can advance rapidly and frequently appear in early life, thus surgical intervention returning the spine to a natural position is usually done in early childhood to improve breathing and posture14

Summary

Loeys-Dietz Syndrome (LDS) is a rare genetic connective tissue disorder typically characterised by cardiovascular manifestations notably including aortic aneurysms (enlargement of aorta) as well as skeletal abnormalities, and craniofacial features. Medical interventions currently focus on reducing acute risks such as aortic dissections and improving quality of life through surgeries to improve core functions like breathing and walking. Angiotensin receptor blockers (ARBs), such Losartan, are a popular treatment for LDS because of their capacity to suppress the hyperactive TGF-β signalling pathway that is essential to LDS disease progression, beta-blockers are also utilised to lower blood pressure and lessen aortic stress.

Many patients still need surgery even with medicinal management. Aortic management includes aortic root replacement or valve-sparing aortic root replacement. Furthermore, when conservative treatment is unsuccessful, orthopaedic treatments are utilised to rectify spinal deformities, anomalies of the chest wall or clubfoot. Additionally, craniofacial surgeries are carried out in some LDS patients to address manifestations of cleft palate or craniosynostosis.

References

  • Gouda P, Kay R, Habib M, Aziz A, Aziza E, Welsh R. Clinical features and complications of Loeys-Dietz syndrome: A systematic review. International Journal of Cardiology [Internet]. 2022 [cited 2025 May 23]; 362:158–67. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0167527322008130.
  • Loeys BL, Dietz HC. Loeys-Dietz Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2025 May 23]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1133/.
  • Hughes GC. Aggressive Aortic Replacement for Loeys-Dietz Syndrome. Tex Heart Inst J [Internet]. 2011 [cited 2025 May 23]; 38(6):663–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233316/.
  • Spinardi L, Vornetti G, De Martino S, Golfieri R, Faccioli L, Pastore Trossello M, et al. Intracranial Arterial Tortuosity in Marfan Syndrome and Loeys-Dietz Syndrome: Tortuosity Index Evaluation Is Useful in the Differential Diagnosis. AJNR Am J Neuroradiol [Internet]. 2020 [cited 2025 May 23]; 41(10):1916–22. Available from: http://www.ajnr.org/lookup/doi/10.3174/ajnr.A6732.
  • Vornetti G, Spinardi L, Mariucci E, Graziano C, Baroni MC, Faccioli L, et al. Increased intracranial arterial tortuosity is associated with worse cardiovascular outcome in patients with Loeys-Dietz syndrome. Journal of Clinical Neuroscience [Internet]. 2022 [cited 2025 May 23]; 96:38–42. Available from: https://www.sciencedirect.com/science/article/pii/S0967586821006147.
  • Levy D, Sharma S, Grigorova Y, Farci F, Le JK. Aortic Dissection. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 May 23]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK441963/.
  • The Loeys–Dietz syndrome. Arch Dis Child [Internet]. 2007 [cited 2025 May 23]; 92(2):119. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2083338/.
  • Schepers D, Tortora G, Morisaki H, MacCarrick G, Lindsay M, Liang D, et al. A mutation update on the LDS‐associated genes TGFB2/3 and SMAD2/3. Hum Mutat [Internet]. 2018 [cited 2025 May 23]; 39(5):621–34. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947146/.
  • Farzam K, Jan A. Beta Blockers. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 May 23]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK532906/.
  • Gallo EM, Loch DC, Habashi JP, Calderon JF, Chen Y, Bedja D, et al. Angiotensin II–dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest [Internet]. 2014 [cited 2025 May 23]; 124(1):448–60. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871227/.
  • Patel ND, Arnaoutakis GJ, George TJ, Allen JG, Alejo DE, Dietz HC, et al. Valve-sparing aortic root replacement in Loeys-Dietz syndrome. Ann Thorac Surg. 2011; 92(2):556–60; discussion 560-561.
  • Zaza P, Indrio F, Fracchiolla A, Rinaldi M, Meliota G, Salatto A, et al. Cleft Palate and Aortic Dilatation as Clues for Loeys–Dietz Syndrome. Children (Basel) [Internet]. 2022 [cited 2025 May 23]; 9(9):1290. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497579/.
  • Sacco Casamassima MG, Wong LL, Papandria D, Abdullah F, Vricella LA, Cameron DE, et al. Modified Nuss Procedure in Concurrent Repair of Pectus Excavatum and Open Heart Surgery. The Annals of Thoracic Surgery [Internet]. 2013 [cited 2025 May 23]; 95(3):1043–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0003497512024939.
  • Bressner JA, MacCarrick GL, Dietz HC, Sponseller PD. Management of Scoliosis in Patients With Loeys-Dietz Syndrome. J Pediatr Orthop. 2017; 37(8):e492–9.

Share

Ishwaq Abdullahi

MSc in Drug Discovery and Pharma Management, University College London (UCL)

Ishwaq is a healthcare professional with a comprehensive background in biomedical sciences, drug development, and pharmaceutical business. Her work spans the NHS, private healthcare, and life sciences consulting, where she has explored approaches to health optimisation and improved healthcare outcomes. Her research has specifically examined market dynamics and patient access challenges for innovative treatments throughout Europe, giving her a nuanced understanding of healthcare ecosystems. Ishwaq is dedicated to translating complex medical concepts into clear, evidence-based content that bridges knowledge gaps between patients, providers, and stakeholders. Through critical analysis and communication, she contributes to advancing healthcare literacy and patient empowerment.

arrow-right